There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
RAVULIZUMAB (rav ue LIZ ue mab) treats certain blood conditions that can cause low levels of red blood cells (anemia) and blood clots, such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). It works by slowing down an overactive immune system, which reduces the breakdown of red blood cells. It also prevents blood cells (platelets) from forming a clot. It may also be used to treat a condition that causes muscles to easily weaken or fatigue (myasthenia gravis). It is a monoclonal antibody.
|
RAVULIZUMAB (rav ue LIZ ue mab) treats certain blood conditions that can cause low levels of red blood cells (anemia) and blood clots, such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). It works by slowing down an overactive immune system, which reduces the breakdown of red blood cells. It also prevents blood cells (platelets) from forming a clot. It may also be used to treat a condition that causes muscles to easily weaken or fatigue (myasthenia gravis). It is a monoclonal antibody.
|
|
LOPERAMIDE (loe PER a mide) treats occasional diarrhea. It works by slowing down an overactive bowel, which decreases the number of bowel movements. It belongs to a group of medications called antidiarrheals. It is often used for a short period of time.
|
LOPERAMIDE (loe PER a mide) treats occasional diarrhea. It works by slowing down an overactive bowel, which decreases the number of bowel movements. It belongs to a group of medications called antidiarrheals. It is often used for a short period of time.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
CALCIUM; VITAMIN D (KAL see um; VYE ta min D) is a vitamin supplement. It is used to prevent conditions of low calcium and vitamin D.
|
CALCIUM; VITAMIN D (KAL see um; VYE ta min D) is a vitamin supplement. It is used to prevent conditions of low calcium and vitamin D.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|